KURA ONCOLOGY, INC. Increase (Decrease) in Interest Payable, Net
KURA ONCOLOGY, INC. (KURA) reported Increase (Decrease) in Interest Payable, Net of $24.00 thousand for the 85-month period ending 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2015-02-27
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for the quarter ending 2014-12-31 was $1.89K, a 13.71% increase year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for the quarter ending 2014-09-30 was $1.66K, a 0.06% decline year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for the quarter ending 2014-06-30 was $1.65K, a 27.22% increase year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for the quarter ending 2014-03-31 was $1.63K, a 29.51% increase year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for fiscal 2014 was $6.83K, a 16.16% increase from fiscal 2013.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for fiscal 2013 was $5.88K, a 18.15% increase from fiscal 2012.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for fiscal 2012 was $4.97K, a 38.17% increase from fiscal 2011.
- KURA ONCOLOGY, INC. increase (decrease) in interest payable, net for fiscal 2011 was $3.60K, a 90.88% increase from fiscal 2010.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 49 month | Increase (Decrease) in Interest Payable, Net 52 month | Increase (Decrease) in Interest Payable, Net 55 month | Increase (Decrease) in Interest Payable, Net 58 month | Increase (Decrease) in Interest Payable, Net 62 month | Increase (Decrease) in Interest Payable, Net 64 month | Increase (Decrease) in Interest Payable, Net 67 month | Increase (Decrease) in Interest Payable, Net 70 month | Increase (Decrease) in Interest Payable, Net 73 month | Increase (Decrease) in Interest Payable, Net 76 month | Increase (Decrease) in Interest Payable, Net 79 month | Increase (Decrease) in Interest Payable, Net 82 month | Increase (Decrease) in Interest Payable, Net 85 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $1.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $3.55K derived: sum of 2 quarters · filed 2015-02-27 | $5.20K derived: sum of 3 quarters · filed 2015-02-27 | $6.83K 10-K · filed 2015-02-27 | $24.00K 10-K · filed 2015-02-27 | ||||||||||||
| 2014-09-30 | $1.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $3.31K derived: sum of 2 quarters · filed 2014-11-14 | $4.94K 10-Q · filed 2014-11-14 | $6.60K derived: sum of 4 quarters · filed 2015-02-27 | $22.11K 10-Q · filed 2014-11-14 | ||||||||||||
| 2014-06-30 | $1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $3.27K 10-Q · filed 2014-08-14 | $4.94K derived: sum of 3 quarters · filed 2015-02-27 | $6.60K derived: sum of 4 quarters · filed 2015-02-27 | $20.45K 10-Q · filed 2014-08-14 | ||||||||||||
| 2014-03-31 | $1.63K 10-Q · filed 2014-05-15 | $3.29K derived: sum of 2 quarters · filed 2015-02-27 | $4.96K derived: sum of 3 quarters · filed 2015-02-27 | $6.25K derived: sum of 4 quarters · filed 2015-02-27 | $18.80K 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $1.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $3.33K derived: sum of 2 quarters · filed 2015-02-27 | $4.62K derived: sum of 3 quarters · filed 2015-02-27 | $5.88K 10-K · filed 2015-02-27 | $17.18K 10-K · filed 2014-03-31 | ||||||||||||
| 2013-09-30 | $1.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.96K derived: sum of 2 quarters · filed 2014-11-14 | $4.21K 10-Q · filed 2014-11-14 | $5.50K derived: sum of 4 quarters · filed 2014-11-14 | $15.51K 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $1.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.55K 10-Q · filed 2014-08-14 | $3.84K derived: sum of 3 quarters · filed 2014-08-14 | $5.12K derived: sum of 4 quarters · filed 2014-08-14 | $13.85K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $1.26K 10-Q · filed 2014-05-15 | $2.54K derived: sum of 2 quarters · filed 2014-05-15 | $3.83K derived: sum of 3 quarters · filed 2014-05-15 | $5.10K derived: sum of 4 quarters · filed 2014-05-15 | $12.55K 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | $1.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.57K derived: sum of 2 quarters · filed 2014-03-31 | $3.84K derived: sum of 3 quarters · filed 2014-03-31 | $4.97K 10-K · filed 2014-03-31 | $11.30K 10-K · filed 2013-03-28 | ||||||||||||
| 2012-09-30 | $1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.56K derived: sum of 2 quarters · filed 2013-11-14 | $3.69K 10-Q · filed 2013-11-14 | $4.59K derived: sum of 4 quarters · filed 2013-11-14 | $10.01K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $1.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $2.40K 10-Q · filed 2013-08-14 | $3.31K derived: sum of 3 quarters · filed 2013-08-14 | $4.22K derived: sum of 4 quarters · filed 2013-08-14 | $8.73K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $1.13K 10-Q · filed 2013-05-15 | $2.04K derived: sum of 2 quarters · filed 2013-05-15 | $2.95K derived: sum of 3 quarters · filed 2013-05-15 | $3.84K derived: sum of 4 quarters · filed 2013-05-15 | $7.46K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $907.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.81K derived: sum of 2 quarters · filed 2013-03-28 | $2.71K derived: sum of 3 quarters · filed 2013-03-28 | $3.60K 10-K · filed 2013-03-28 | $6.32K 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $908.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.80K derived: sum of 2 quarters · filed 2012-11-14 | $2.69K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | $897.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.78K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $888.00 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $1.89K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |